Trump Imposes Tariffs on Drugs and Pharma.
The United States is planning to put taxes on medicines made in Europe. Some companies are changing their plans to avoid these taxes. This could affect trade between the US and Europe.
The US government is using a law called Section 232 to do this. This law is used to protect American industries. The US wants to make medicines more expensive. It also wants companies to make their medicines in America. This is causing problems for companies in Europe. There are worries about how this will affect the price of medicines in Europe.
Summarized from the sources above. Read the originals for the full story.
Highlights
Tariffs Imposed on Drugs
The Trump administration is imposing tariffs on prescription drugs and active pharmaceutical ingredients.
Section 232 Used
The tariffs use Section 232 of the Trade Expansion Act.
Companies Agree to Changes
Some companies have agreed to set prices or move production to the US.
Trade Concerns Raised
The action raises concerns about trade relations between the US and Europe.
Price Increase Aimed
The move aims to increase drug prices and pressure companies.